DNA methylation signal of birthweight generalizes to high-risk pregnancies and is independent of genetic, maternal, and obstetric factors: a twin study
DNA methylation is associated with individual differences in birthweight in a high-risk clinical population of MC twins, independent of shared genetic, familial, maternal, and obstetric factors.
Abstract
Background. DNA methylation patterns in cord blood are robustly associated with birthweight in the general population. However, it remains unknown whether these associations extend to clinically relevant populations, such as preterm neonates or those born small for gestational age, and whether they directly reflect birthweight or are driven indirectly by genetic, familial, maternal, and obstetric factors. Methods. We calculated a birthweight methylation profile score (MPSBW) using weights of 835 CpGs previously associated with birthweight in the general population and evaluated its association with birthweight in 67 monochorionic (MC) twin pairs including 134 neonates (97% born preterm) from the Twinlife study. MC twin pairs are identical twins sharing a single placenta, often unequally, which can result in unequal resource distribution and differential fetal growth. Results. We examined the association between within-pair differences in birthweight and MPSBW, thereby estimating the association independent of factors shared equally by co-twins. A 500-gram increase in birthweight was associated with a 0.256 SD increase in MPSBW (p<0.005) in this population of preterm neonates. Adjustment for polygenic score for birthweight (PGSBW) confirmed that the observed epigenetic associations were not driven by common genetic variation underlying birthweight. Interestingly, a similar effect size (0.226 SD per 500 g birthweight increase; p<0.05) was observed in the within-pair analysis, which controls for all shared influences within a twin pair. Conclusion DNA methylation is associated with individual differences in birthweight in a high-risk clinical population of MC twins, independent of shared genetic, familial or maternal influences.
In this pilot study, LGA was associated with modest cord blood DNAm differences, although no CpG sites reached genome-wide significance, suggesting candidate loci for further evaluation in larger studies of fetal overgrowth.
Xiao-Yu Liang, Christopher Doumith, Dawn P. Misra et al.· Epigenomes· 0 citations
A role of DNAm at birth in mediating the association of maternal smoking, birth weight and ADHD-related genetic variants with ADHD symptoms is demonstrated, however, lack of individual site-specific findings and the observational design limit causal biological interpretations.
A. Neumann, M. Suderman, J. Felix et al.· medRxiv· 0 citations
Functional enrichment analysis highlighted the pathways involved in early embryonic development and placental function, implicating early-pregnancy maternal epigenetic alterations in SGA delivery among Black women and supporting DNA methylation profiling as a potential SGA biomarker.
Paolo Reho, Ting-Ting Zhao, Yi-Hong Zhao et al.· Epigenetics Insights· 0 citations
This review highlights recent methodological advances in genomic research designed to disentangle maternal and fetal genetic effects and explores approaches to characterizing the genetic architecture of pregnancy phenotypes, including methods for partitioning maternal and fetal genetic contributions and genetic correla...
Ge Zhang, R. Freathy, B. Jacobsson et al.· Frontiers in Genetics· 0 citations
Background. Cord blood DNA methylation profile scores (MPSs) based on genetic and pre-/perinatal risk factors for neurodevelopmental conditions (NDCs) may capture downstream biological effects and help understand how combined exposure signals contribute to NDC risk. Methods. Using data from two longitudinal birth cohor...
Elena Isaevska, Rosa H. Mulder, I. Schuurmans et al.· medRxiv· 0 citations
The Barker-consistent hypothesis-free discovery approach identified novel and known candidate genes that, with future validation, may serve as therapeutic targets, identify high-risk individuals, and support clinical trial recruitment.
John Yen Tang, N. Ng, A. S. Kwok et al.· Journal of Global Health· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.